Literature DB >> 10717335

Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study.

P García-Corbeira1, R Dal-Ré, L Aguilar, J García-de-Lomas.   

Abstract

A study was conducted on a representative sample (n=4084) of the Spanish population to assess the prevalence of antibodies to pertussis toxin (PT) and filamentous hemagglutinin (FHA). A total of 1982 men and 2102 women aged 5-59 years were stratified by sex and age (5-12, 13-19, 20-29, 30-39, 40-49 and 50-59 years). Antibodies to PT were found in 46% samples and to FHA in 74% and increased with age (p<0.0001), ranging from 35% in the 5-12 year age group to 52% in the 50-59 year age group for anti-PT and from 65 to 80% for anti-FHA, respectively. As vaccine induced-immunity wanes over time, the observed age distribution of antibodies suggests that Bordetella pertussis infection is widespread in the Spanish population and that pertussis booster vaccination in adolescents and adults with the newly developed acellular vaccines, should be considered if it is deemed necessary to control the circulation of the organism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10717335     DOI: 10.1016/s0264-410x(00)00029-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  [Immunization: Leaps into the future. Foreseeable changes in children's vaccination calendar in the coming years].

Authors:  J Pericas Bosch
Journal:  Aten Primaria       Date:  2003-03-31       Impact factor: 1.137

2.  Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles.

Authors:  Abdolreza Advani; Declan Donnelly; Hans Hallander
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

3.  Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece.

Authors:  A Polyzou; S Pournaras; U Dafni; D Sofianou; E Christeli; S Patrinos; A Tsakris
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

4.  Bordetella pertussis IgG and IgA antibodies seroprevalence among 1-35 y-old population: the role of subclinical pertussis infection.

Authors:  Mohammed-Jafar Saffar; Ali-Reza Khalilian; Ali-Reza Rafee; Mohammed Reza Parsaei; Shadi Imanikhani; Jalil Shojaei; Hana Saffar
Journal:  Indian J Pediatr       Date:  2011-11-22       Impact factor: 1.967

5.  Antibody response from whole-cell pertussis vaccine immunized Brazilian children against different strains of Bordetella pertussis.

Authors:  Alexandre Pereira; Aparecida S Pietro Pereira; Célio Lopes Silva; Gutemberg de Melo Rocha; Ivo Lebrun; Osvaldo A Sant'Anna; Denise V Tambourgi
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

6.  Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Merete Bolstad; Synne Sandbu; Hilde Bakke; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

7.  The seroepidemiology of pertussis in Australia during an epidemic period.

Authors:  M Cagney; C R MacIntyre; P McIntyre; M Puech; A Giammanco
Journal:  Epidemiol Infect       Date:  2006-05-11       Impact factor: 2.451

8.  Seroprevalence of pertussis in China: need to improve vaccination strategies.

Authors:  Yinghua Xu; Lichan Wang; Jin Xu; Xinjian Wang; Chen Wei; Peng Luo; Xiao Ma; Qiming Hou; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-09-09       Impact factor: 3.452

9.  Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain.

Authors:  Alba González-Escalada; Laura García-García; Pablo Viguera-Ester; Patricia Marín-García; Jesus García; Angel Gil-de-Miguel; Ruth Gil-Prieto
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

10.  Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children.

Authors:  Markus Ringler; Georg Göbel; Johannes Möst; Kurt Weithaler
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.